Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.02 (-1.31%)
Close on Nov 18, 2026Market cap $1.98MP/E –Yield –
Can-Fite BioPharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 2M, up 127.0% from the year before. Over ten years it grew 239.9% a year on average. The highest annual figure on record is 2M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2M | +127.0% |
| FY2024 | Dec 31, 2024 | 1M | +70.2% |
| FY2023 | Dec 31, 2023 | 0M | +56.7% |
| FY2022 | Dec 31, 2022 | 0M | +47.5% |
| FY2021 | Dec 31, 2021 | 0M | +54.3% |
| FY2020 | Dec 31, 2020 | 0M | +317.2% |
| FY2019 | Dec 31, 2019 | 0M | +120.8% |
| FY2018 | Dec 31, 2018 | 0M | +19.6% |
| FY2017 | Dec 31, 2017 | 0M | +17.5% |
| FY2016 | Dec 31, 2016 | 0M | +115287.5% |
| FY2015 | Dec 31, 2015 | 0M | – |
See a number that looks wrong?